CARBIDOPA AND LEVODOPA
NDC 16729-079, Carbidopa and Levodopa, tablet, extended release, from Accord Healthcare, Inc..
- Product NDC
- 16729-079
- Status
- Listed
- Labeler
- Accord Healthcare, Inc.
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA202323
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/16729-079 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CARBIDOPA50 mg/1
- LEVODOPA200 mg/1
Pharmacologic classes
Amino Acids, Aromatic [CS]; Aromatic Amino Acid [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 16729-079-01 | 16729007901 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (16729-079-01) |
| 16729-079-17 | 16729007917 | 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (16729-079-17) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/5217a6ec-cc26-4acc-b2da-17f6545c3b60
Use it
Look up 16729-079 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/16729-079 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 16729-079. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.